The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pediatric Drugs-Global Market Insights and Sales Trends 2024

Pediatric Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1856357

No of Pages : 119

Ask Your Query
Synopsis
The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.
The global Pediatric Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Drugs in various end use industries. The expanding demands from the Hospital, Clinic and Drugstore,, are propelling Pediatric Drugs market. Allergy and Respiratory Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Infectives segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Drugs covered in this report include Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech and GlaxoSmithKline, etc.
The global Pediatric Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough
Global Pediatric Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Drugs market, Segment by Type:
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs
Global Pediatric Drugs market, by Application
Hospital
Clinic
Drugstore
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pediatric Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pediatric Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Pediatric Drugs Market Overview
1.1 Pediatric Drugs Product Overview
1.2 Pediatric Drugs Market Segment by Type
1.2.1 Allergy and Respiratory Drugs
1.2.2 Anti-Infectives
1.2.3 Cancer Therapies
1.2.4 Cardiovascular Drugs
1.2.5 Central Nervous System Drugs
1.2.6 Gastrointestinal Drugs
1.2.7 Hormone Drugs
1.2.8 Urological Drugs
1.3 Global Pediatric Drugs Market Size by Type
1.3.1 Global Pediatric Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Pediatric Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pediatric Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pediatric Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pediatric Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Type (2018-2023)
2 Global Pediatric Drugs Market Competition by Company
2.1 Global Top Players by Pediatric Drugs Sales (2018-2023)
2.2 Global Top Players by Pediatric Drugs Revenue (2018-2023)
2.3 Global Top Players by Pediatric Drugs Price (2018-2023)
2.4 Global Top Manufacturers Pediatric Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Drugs Market Competitive Situation and Trends
2.5.1 Pediatric Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Pediatric Drugs Market
2.8 Key Manufacturers Pediatric Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Drugs Status and Outlook by Region
3.1 Global Pediatric Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pediatric Drugs Historic Market Size by Region
3.2.1 Global Pediatric Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Pediatric Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Pediatric Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pediatric Drugs Forecasted Market Size by Region
3.3.1 Global Pediatric Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Pediatric Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Pediatric Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pediatric Drugs by Application
4.1 Pediatric Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drugstore
4.2 Global Pediatric Drugs Market Size by Application
4.2.1 Global Pediatric Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Pediatric Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pediatric Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pediatric Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pediatric Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Application (2018-2023)
5 North America Pediatric Drugs by Country
5.1 North America Pediatric Drugs Historic Market Size by Country
5.1.1 North America Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pediatric Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Pediatric Drugs Sales in Value by Country (2018-2023)
5.2 North America Pediatric Drugs Forecasted Market Size by Country
5.2.1 North America Pediatric Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Pediatric Drugs Sales in Value by Country (2024-2029)
6 Europe Pediatric Drugs by Country
6.1 Europe Pediatric Drugs Historic Market Size by Country
6.1.1 Europe Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pediatric Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Pediatric Drugs Sales in Value by Country (2018-2023)
6.2 Europe Pediatric Drugs Forecasted Market Size by Country
6.2.1 Europe Pediatric Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Pediatric Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Pediatric Drugs by Region
7.1 Asia-Pacific Pediatric Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pediatric Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pediatric Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pediatric Drugs Sales in Value by Region (2024-2029)
8 Latin America Pediatric Drugs by Country
8.1 Latin America Pediatric Drugs Historic Market Size by Country
8.1.1 Latin America Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pediatric Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pediatric Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Pediatric Drugs Forecasted Market Size by Country
8.2.1 Latin America Pediatric Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pediatric Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Pediatric Drugs by Country
9.1 Middle East and Africa Pediatric Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pediatric Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pediatric Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pediatric Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories Pediatric Drugs Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Pediatric Drugs Products Offered
10.2.5 Bayer Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Pediatric Drugs Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bristol-Myers Squibb Pediatric Drugs Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Colgate Oral Pharmaceuticals
10.5.1 Colgate Oral Pharmaceuticals Company Information
10.5.2 Colgate Oral Pharmaceuticals Introduction and Business Overview
10.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Products Offered
10.5.5 Colgate Oral Pharmaceuticals Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Eli Lilly Pediatric Drugs Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Forest Laboratories
10.7.1 Forest Laboratories Company Information
10.7.2 Forest Laboratories Introduction and Business Overview
10.7.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Forest Laboratories Pediatric Drugs Products Offered
10.7.5 Forest Laboratories Recent Development
10.8 Genentech
10.8.1 Genentech Company Information
10.8.2 Genentech Introduction and Business Overview
10.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Genentech Pediatric Drugs Products Offered
10.8.5 Genentech Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GlaxoSmithKline Pediatric Drugs Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information
10.10.2 Johnson & Johnson Introduction and Business Overview
10.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Johnson & Johnson Pediatric Drugs Products Offered
10.10.5 Johnson & Johnson Recent Development
10.11 MedImmune
10.11.1 MedImmune Company Information
10.11.2 MedImmune Introduction and Business Overview
10.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 MedImmune Pediatric Drugs Products Offered
10.11.5 MedImmune Recent Development
10.12 Merck
10.12.1 Merck Company Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Merck Pediatric Drugs Products Offered
10.12.5 Merck Recent Development
10.13 Novartis Pharmaceuticals
10.13.1 Novartis Pharmaceuticals Company Information
10.13.2 Novartis Pharmaceuticals Introduction and Business Overview
10.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Novartis Pharmaceuticals Pediatric Drugs Products Offered
10.13.5 Novartis Pharmaceuticals Recent Development
10.14 Novo Nordisk
10.14.1 Novo Nordisk Company Information
10.14.2 Novo Nordisk Introduction and Business Overview
10.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Novo Nordisk Pediatric Drugs Products Offered
10.14.5 Novo Nordisk Recent Development
10.15 Pfizer
10.15.1 Pfizer Company Information
10.15.2 Pfizer Introduction and Business Overview
10.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Pfizer Pediatric Drugs Products Offered
10.15.5 Pfizer Recent Development
10.16 Pharmacia
10.16.1 Pharmacia Company Information
10.16.2 Pharmacia Introduction and Business Overview
10.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Pharmacia Pediatric Drugs Products Offered
10.16.5 Pharmacia Recent Development
10.17 Roche
10.17.1 Roche Company Information
10.17.2 Roche Introduction and Business Overview
10.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Roche Pediatric Drugs Products Offered
10.17.5 Roche Recent Development
10.18 Schering-Plough
10.18.1 Schering-Plough Company Information
10.18.2 Schering-Plough Introduction and Business Overview
10.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Schering-Plough Pediatric Drugs Products Offered
10.18.5 Schering-Plough Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Drugs Industrial Chain Analysis
11.4 Pediatric Drugs Market Dynamics
11.4.1 Pediatric Drugs Industry Trends
11.4.2 Pediatric Drugs Market Drivers
11.4.3 Pediatric Drugs Market Challenges
11.4.4 Pediatric Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Drugs Distributors
12.3 Pediatric Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock